Tony Wyss-Coray

"To try to translate that we started a company Alkahest to see whether factors from the blood of individuals could influence first of all aging of a mouse brain."

"We started a company with Paul Ketta called Vero Biosciences. And the mission is really to profile the age of organs to ideally eradicate chronic diseases."

"The Vero Compass uses a combination of this biological signature together with clinical and wearable data to create a platform that can predict how you respond."

"That's exactly what we recognized at Vero where we want to have tailored interventions that you give very specific advice based on if your heart is showing accelerated aging."